

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.78356201 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.78356201 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.56670610 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.56670610 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.38631924 |
| 6 | tryptophan catabolic process (GO:0006569) | 5.09272097 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.09272097 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.09272097 |
| 9 | tryptophan metabolic process (GO:0006568) | 4.74792975 |
| 10 | sulfur amino acid catabolic process (GO:0000098) | 4.67468042 |
| 11 | kynurenine metabolic process (GO:0070189) | 4.65917266 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.46414093 |
| 13 | bile acid biosynthetic process (GO:0006699) | 4.45316624 |
| 14 | high-density lipoprotein particle remodeling (GO:0034375) | 4.35216495 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 4.15250597 |
| 16 | glyoxylate metabolic process (GO:0046487) | 4.14588846 |
| 17 | complement activation, alternative pathway (GO:0006957) | 4.12314749 |
| 18 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.11697551 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.08350520 |
| 20 | bile acid metabolic process (GO:0008206) | 4.07503418 |
| 21 | urea cycle (GO:0000050) | 4.01585072 |
| 22 | urea metabolic process (GO:0019627) | 4.01585072 |
| 23 | cholesterol efflux (GO:0033344) | 3.95858481 |
| 24 | acylglycerol homeostasis (GO:0055090) | 3.91486408 |
| 25 | triglyceride homeostasis (GO:0070328) | 3.91486408 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.89740188 |
| 27 | protein carboxylation (GO:0018214) | 3.89740188 |
| 28 | regulation of cholesterol esterification (GO:0010872) | 3.88959005 |
| 29 | regulation of protein activation cascade (GO:2000257) | 3.85269008 |
| 30 | aromatic amino acid family metabolic process (GO:0009072) | 3.84123988 |
| 31 | phospholipid efflux (GO:0033700) | 3.83127583 |
| 32 | reverse cholesterol transport (GO:0043691) | 3.78190989 |
| 33 | cysteine metabolic process (GO:0006534) | 3.77987269 |
| 34 | nitrogen cycle metabolic process (GO:0071941) | 3.77485739 |
| 35 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.71450892 |
| 36 | drug catabolic process (GO:0042737) | 3.70202493 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 3.70146208 |
| 38 | homocysteine metabolic process (GO:0050667) | 3.64284190 |
| 39 | indolalkylamine metabolic process (GO:0006586) | 3.63657281 |
| 40 | amine catabolic process (GO:0009310) | 3.62376072 |
| 41 | cellular biogenic amine catabolic process (GO:0042402) | 3.62376072 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 3.60742800 |
| 43 | macromolecular complex remodeling (GO:0034367) | 3.60742800 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 3.60742800 |
| 45 | regulation of complement activation (GO:0030449) | 3.60722179 |
| 46 | amino-acid betaine metabolic process (GO:0006577) | 3.55308245 |
| 47 | alpha-amino acid catabolic process (GO:1901606) | 3.54736101 |
| 48 | NAD biosynthetic process (GO:0009435) | 3.53871471 |
| 49 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.53806572 |
| 50 | negative regulation of cell killing (GO:0031342) | 3.53806572 |
| 51 | negative regulation of fibrinolysis (GO:0051918) | 3.53554752 |
| 52 | regulation of triglyceride catabolic process (GO:0010896) | 3.50420447 |
| 53 | tyrosine metabolic process (GO:0006570) | 3.50205335 |
| 54 | alkaloid metabolic process (GO:0009820) | 3.49630413 |
| 55 | glycosphingolipid catabolic process (GO:0046479) | 3.49312178 |
| 56 | regulation of fibrinolysis (GO:0051917) | 3.46403319 |
| 57 | cytolysis (GO:0019835) | 3.42532092 |
| 58 | low-density lipoprotein particle remodeling (GO:0034374) | 3.42422891 |
| 59 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.38773834 |
| 60 | cellular amino acid catabolic process (GO:0009063) | 3.38533182 |
| 61 | coenzyme catabolic process (GO:0009109) | 3.35514296 |
| 62 | plasma lipoprotein particle assembly (GO:0034377) | 3.31993855 |
| 63 | proline metabolic process (GO:0006560) | 3.31194035 |
| 64 | glutamate metabolic process (GO:0006536) | 3.29854313 |
| 65 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.25245236 |
| 66 | intestinal cholesterol absorption (GO:0030299) | 3.21657316 |
| 67 | bile acid and bile salt transport (GO:0015721) | 3.21020137 |
| 68 | benzene-containing compound metabolic process (GO:0042537) | 3.19993692 |
| 69 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.19601632 |
| 70 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.17800823 |
| 71 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.17800823 |
| 72 | glycolipid catabolic process (GO:0019377) | 3.15779996 |
| 73 | imidazole-containing compound metabolic process (GO:0052803) | 3.14435014 |
| 74 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.11781259 |
| 75 | detection of molecule of bacterial origin (GO:0032490) | 3.09699123 |
| 76 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.08306547 |
| 77 | proline biosynthetic process (GO:0006561) | 3.08256212 |
| 78 | plasma lipoprotein particle organization (GO:0071827) | 3.05521730 |
| 79 | exogenous drug catabolic process (GO:0042738) | 3.02927324 |
| 80 | phospholipid homeostasis (GO:0055091) | 3.02104928 |
| 81 | valine metabolic process (GO:0006573) | 3.01263794 |
| 82 | negative regulation of sterol transport (GO:0032372) | 3.01145759 |
| 83 | negative regulation of cholesterol transport (GO:0032375) | 3.01145759 |
| 84 | organic acid catabolic process (GO:0016054) | 3.01009289 |
| 85 | carboxylic acid catabolic process (GO:0046395) | 3.01009289 |
| 86 | short-chain fatty acid metabolic process (GO:0046459) | 2.99578337 |
| 87 | regulation of cholesterol homeostasis (GO:2000188) | 2.99041092 |
| 88 | regulation of beta-amyloid formation (GO:1902003) | 2.98254095 |
| 89 | cofactor catabolic process (GO:0051187) | 2.97540778 |
| 90 | cellular glucuronidation (GO:0052695) | 2.97241277 |
| 91 | cellular modified amino acid catabolic process (GO:0042219) | 2.94903928 |
| 92 | macrophage activation involved in immune response (GO:0002281) | 2.93646965 |
| 93 | regulation of bile acid biosynthetic process (GO:0070857) | 2.93587870 |
| 94 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.92340607 |
| 95 | cellular ketone body metabolic process (GO:0046950) | 2.90105398 |
| 96 | complement activation, classical pathway (GO:0006958) | 2.89819300 |
| 97 | monocarboxylic acid catabolic process (GO:0072329) | 2.86771273 |
| 98 | lysine catabolic process (GO:0006554) | 2.86767046 |
| 99 | lysine metabolic process (GO:0006553) | 2.86767046 |
| 100 | drug transmembrane transport (GO:0006855) | 2.86720901 |
| 101 | plasma lipoprotein particle clearance (GO:0034381) | 2.85946290 |
| 102 | neutrophil activation involved in immune response (GO:0002283) | 2.85635107 |
| 103 | protein-lipid complex assembly (GO:0065005) | 2.84247503 |
| 104 | opsonization (GO:0008228) | 2.84222654 |
| 105 | regulation of protein homooligomerization (GO:0032462) | 2.84127075 |
| 106 | peptide catabolic process (GO:0043171) | 2.83842367 |
| 107 | protein localization to endosome (GO:0036010) | 2.83249493 |
| 108 | fatty acid oxidation (GO:0019395) | 2.83052030 |
| 109 | complement activation (GO:0006956) | 2.82511475 |
| 110 | fatty acid beta-oxidation (GO:0006635) | 2.82464381 |
| 111 | negative regulation of lipase activity (GO:0060192) | 2.81704494 |
| 112 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.80519630 |
| 113 | lipid oxidation (GO:0034440) | 2.79966397 |
| 114 | regulation of mononuclear cell migration (GO:0071675) | 2.79860890 |
| 115 | protein-lipid complex subunit organization (GO:0071825) | 2.79505921 |
| 116 | barbed-end actin filament capping (GO:0051016) | 2.78405983 |
| 117 | response to thyroid hormone (GO:0097066) | 2.76291877 |
| 118 | adhesion of symbiont to host cell (GO:0044650) | 2.75052102 |
| 119 | virion attachment to host cell (GO:0019062) | 2.75052102 |
| 120 | N-acetylneuraminate metabolic process (GO:0006054) | 2.70739781 |
| 121 | ceramide catabolic process (GO:0046514) | 2.69575331 |
| 122 | oligosaccharide catabolic process (GO:0009313) | 2.68716504 |
| 123 | hypotonic response (GO:0006971) | 2.67098285 |
| 124 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.66550258 |
| 125 | apoptotic cell clearance (GO:0043277) | 2.65351263 |
| 126 | negative regulation of interleukin-12 production (GO:0032695) | 2.64756718 |
| 127 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.63942101 |
| 128 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.61311825 |
| 129 | response to peptidoglycan (GO:0032494) | 2.60703730 |
| 130 | detection of external biotic stimulus (GO:0098581) | 2.60165594 |
| 131 | regulation of macrophage chemotaxis (GO:0010758) | 2.59939927 |
| 132 | mannose metabolic process (GO:0006013) | 2.59000333 |
| 133 | positive regulation of Rap GTPase activity (GO:0032854) | 2.57210182 |
| 134 | detection of other organism (GO:0098543) | 2.53732480 |
| 135 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.53574184 |
| 136 | regulation of cellular amide metabolic process (GO:0034248) | 2.52170796 |
| 137 | cellular response to ethanol (GO:0071361) | 2.51885597 |
| 138 | macroautophagy (GO:0016236) | 2.51739200 |
| 139 | keratan sulfate catabolic process (GO:0042340) | 2.50807480 |
| 140 | amino sugar catabolic process (GO:0046348) | 2.50584146 |
| 141 | positive regulation of receptor recycling (GO:0001921) | 2.49932746 |
| 142 | regulation of early endosome to late endosome transport (GO:2000641) | 2.46215749 |
| 143 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.44917227 |
| 144 | adhesion of symbiont to host (GO:0044406) | 2.44662710 |
| 145 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.40967971 |
| 146 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.40967971 |
| 147 | modulation by symbiont of host immune response (GO:0052553) | 2.40967971 |
| 148 | positive regulation by symbiont of host defense response (GO:0052509) | 2.40967971 |
| 149 | modulation by symbiont of host defense response (GO:0052031) | 2.40967971 |
| 150 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.40967971 |
| 151 | positive regulation of leukocyte degranulation (GO:0043302) | 2.40913842 |
| 152 | regulation of gamma-delta T cell activation (GO:0046643) | 2.39137670 |
| 153 | Rap protein signal transduction (GO:0032486) | 2.37584831 |
| 154 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.36469017 |
| 155 | regulation of cholesterol storage (GO:0010885) | 2.36382238 |
| 156 | negative regulation of complement activation (GO:0045916) | 2.36272877 |
| 157 | regulation of apoptotic cell clearance (GO:2000425) | 2.35148943 |
| 158 | cellular extravasation (GO:0045123) | 2.34190121 |
| 159 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.33492345 |
| 160 | T-helper 1 type immune response (GO:0042088) | 2.32723299 |
| 161 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.32642524 |
| 162 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.31185113 |
| 163 | positive regulation of cholesterol efflux (GO:0010875) | 2.29416054 |
| 164 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.29117195 |
| 165 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.29113031 |
| 166 | iron ion import (GO:0097286) | 2.28122884 |
| 167 | nerve growth factor signaling pathway (GO:0038180) | 2.27195812 |
| 168 | immunoglobulin mediated immune response (GO:0016064) | 2.26669840 |
| 169 | positive regulation of cholesterol transport (GO:0032376) | 2.25937126 |
| 170 | positive regulation of sterol transport (GO:0032373) | 2.25937126 |
| 171 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.25536545 |
| 172 | membrane lipid catabolic process (GO:0046466) | 2.24986891 |
| 173 | cortical cytoskeleton organization (GO:0030865) | 2.24821123 |
| 174 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.24790632 |
| 175 | positive regulation of macrophage cytokine production (GO:0060907) | 2.24272693 |
| 176 | regulation of ARF protein signal transduction (GO:0032012) | 2.22898239 |
| 177 | macrophage activation (GO:0042116) | 2.21609402 |
| 178 | negative regulation of humoral immune response (GO:0002921) | 2.21563121 |
| 179 | sphingolipid catabolic process (GO:0030149) | 2.20744619 |
| 180 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.20304243 |
| 181 | detection of bacterium (GO:0016045) | 2.20218645 |
| 182 | angiotensin maturation (GO:0002003) | 2.19878149 |
| 183 | positive regulation of type 2 immune response (GO:0002830) | 2.19831274 |
| 184 | detection of biotic stimulus (GO:0009595) | 2.18584188 |
| 185 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.16551336 |
| 186 | response to laminar fluid shear stress (GO:0034616) | 2.13932429 |
| 187 | negative regulation of protein activation cascade (GO:2000258) | 2.13308079 |
| 188 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.12555505 |
| 189 | regulation of type 2 immune response (GO:0002828) | 2.11890707 |
| 190 | regulation of Rap GTPase activity (GO:0032317) | 2.11632827 |
| 191 | positive regulation of mast cell activation (GO:0033005) | 2.10507752 |
| 192 | regulation of tolerance induction (GO:0002643) | 2.08329799 |
| 193 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.07690232 |
| 194 | regulation of T cell tolerance induction (GO:0002664) | 2.07511769 |
| 195 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.05573156 |
| 196 | negative regulation of interleukin-17 production (GO:0032700) | 2.05342661 |
| 197 | regulation of leukocyte degranulation (GO:0043300) | 2.05062542 |
| 198 | negative regulation of type 2 immune response (GO:0002829) | 2.02617039 |
| 199 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.02369731 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.28805143 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.12930097 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.19451305 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.14352685 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.09363398 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.84094739 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.89611348 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.78505563 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.40745224 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.34302029 |
| 11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.32259491 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.24481258 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.21053581 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.08862476 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.05689534 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.01777357 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.98097791 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.90667976 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.85408986 |
| 20 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.60325941 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.58097673 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.57620388 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56707302 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.46999011 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42466267 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.42179260 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41237169 |
| 28 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.40039732 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38484399 |
| 30 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.37654727 |
| 31 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.34254319 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32608102 |
| 33 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28506619 |
| 34 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.27720601 |
| 35 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26082830 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.24640568 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22874531 |
| 38 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20094082 |
| 39 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.17499267 |
| 40 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15133042 |
| 41 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.14562459 |
| 42 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.14557638 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.14493023 |
| 44 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.11272727 |
| 45 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.11160804 |
| 46 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09876467 |
| 47 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09673580 |
| 48 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.09425672 |
| 49 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.08614219 |
| 50 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07897179 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06897675 |
| 52 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06111020 |
| 53 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.05767767 |
| 54 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.04920098 |
| 55 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.04661845 |
| 56 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04595681 |
| 57 | KDM2B_26808549_Chip-Seq_K562_Human | 1.04387472 |
| 58 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.01269992 |
| 59 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98990833 |
| 60 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.98895823 |
| 61 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.98773434 |
| 62 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.98015685 |
| 63 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.98015685 |
| 64 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.96461899 |
| 65 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95975647 |
| 66 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95709918 |
| 67 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94316472 |
| 68 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.93816010 |
| 69 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.93574541 |
| 70 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.93351965 |
| 71 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.93330767 |
| 72 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.91378223 |
| 73 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.91030745 |
| 74 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90614423 |
| 75 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.90538506 |
| 76 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.90433641 |
| 77 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.90227094 |
| 78 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89204598 |
| 79 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88947431 |
| 80 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88947431 |
| 81 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.88887063 |
| 82 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88671086 |
| 83 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.88049354 |
| 84 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.87586472 |
| 85 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.87249916 |
| 86 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.87194297 |
| 87 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.86389840 |
| 88 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86002866 |
| 89 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.85533224 |
| 90 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85242565 |
| 91 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.84663533 |
| 92 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.84634833 |
| 93 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84629319 |
| 94 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84275707 |
| 95 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.84066285 |
| 96 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83951735 |
| 97 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.83302783 |
| 98 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.83047862 |
| 99 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82801374 |
| 100 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.82267808 |
| 101 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.81868021 |
| 102 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81729678 |
| 103 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.81670899 |
| 104 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.81143031 |
| 105 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.80940648 |
| 106 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.80866223 |
| 107 | CJUN_26792858_Chip-Seq_BT549_Human | 0.80737224 |
| 108 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.80648275 |
| 109 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.80390276 |
| 110 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.79377985 |
| 111 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.79329982 |
| 112 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79115406 |
| 113 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.79028670 |
| 114 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78936224 |
| 115 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.78343433 |
| 116 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.78205419 |
| 117 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.77832866 |
| 118 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.77396615 |
| 119 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.76990540 |
| 120 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.76924909 |
| 121 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.75679914 |
| 122 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.75649023 |
| 123 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.75579504 |
| 124 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.75233524 |
| 125 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.74904180 |
| 126 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.74667811 |
| 127 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.74523637 |
| 128 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.74140678 |
| 129 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.73275268 |
| 130 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.72706826 |
| 131 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.72570685 |
| 132 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.72221173 |
| 133 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.71858623 |
| 134 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.71526173 |
| 135 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.71300343 |
| 136 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.71196692 |
| 137 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.71173122 |
| 138 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.70981187 |
| 139 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.70887984 |
| 140 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.70636982 |
| 141 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.70542148 |
| 142 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.70016994 |
| 143 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.69575098 |
| 144 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.69561790 |
| 145 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.68737856 |
| 146 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.67556096 |
| 147 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.67171624 |
| 148 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.66965770 |
| 149 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.66535709 |
| 150 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.66503715 |
| 151 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.66298025 |
| 152 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.66111369 |
| 153 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.66111369 |
| 154 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.66111369 |
| 155 | P300_19829295_ChIP-Seq_ESCs_Human | 0.65616263 |
| 156 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.65427521 |
| 157 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.65266575 |
| 158 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.65026718 |
| 159 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64689544 |
| 160 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.64646194 |
| 161 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.64495635 |
| 162 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.64131556 |
| 163 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.63757737 |
| 164 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.62268910 |
| 165 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.61735636 |
| 166 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.61674506 |
| 167 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.61497399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.72927539 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 5.57098009 |
| 3 | MP0005360_urolithiasis | 5.43177813 |
| 4 | MP0005365_abnormal_bile_salt | 5.29294059 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.00566322 |
| 6 | MP0003300_gastrointestinal_ulcer | 3.26766361 |
| 7 | MP0003252_abnormal_bile_duct | 3.12840448 |
| 8 | MP0003303_peritoneal_inflammation | 3.08016380 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.82958487 |
| 10 | MP0003195_calcinosis | 2.72427870 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.63660898 |
| 12 | MP0005332_abnormal_amino_acid | 2.38975582 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.23885972 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.23877804 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.11771331 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.07664978 |
| 17 | MP0005083_abnormal_biliary_tract | 2.07075318 |
| 18 | MP0002876_abnormal_thyroid_physiology | 2.03522002 |
| 19 | MP0008004_abnormal_stomach_pH | 2.02304075 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.95816669 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.94285028 |
| 22 | MP0000569_abnormal_digit_pigmentation | 1.94158439 |
| 23 | MP0009840_abnormal_foam_cell | 1.91864679 |
| 24 | MP0002419_abnormal_innate_immunity | 1.84706638 |
| 25 | MP0003329_amyloid_beta_deposits | 1.82339478 |
| 26 | MP0002009_preneoplasia | 1.74875957 |
| 27 | MP0000609_abnormal_liver_physiology | 1.72065536 |
| 28 | MP0002998_abnormal_bone_remodeling | 1.69994570 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.69610756 |
| 30 | MP0001764_abnormal_homeostasis | 1.68613107 |
| 31 | MP0000343_altered_response_to | 1.65939450 |
| 32 | MP0005647_abnormal_sex_gland | 1.56877064 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.53944212 |
| 34 | MP0005319_abnormal_enzyme/_coenzyme | 1.52363790 |
| 35 | MP0009764_decreased_sensitivity_to | 1.52185153 |
| 36 | MP0000015_abnormal_ear_pigmentation | 1.49750354 |
| 37 | MP0005000_abnormal_immune_tolerance | 1.49304042 |
| 38 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.47322862 |
| 39 | MP0001958_emphysema | 1.44710116 |
| 40 | MP0003091_abnormal_cell_migration | 1.43782281 |
| 41 | MP0000920_abnormal_myelination | 1.42286519 |
| 42 | MP0005167_abnormal_blood-brain_barrier | 1.41274816 |
| 43 | MP0005166_decreased_susceptibility_to | 1.38799704 |
| 44 | MP0004947_skin_inflammation | 1.36128563 |
| 45 | MP0003279_aneurysm | 1.32440288 |
| 46 | MP0005535_abnormal_body_temperature | 1.30806845 |
| 47 | MP0003868_abnormal_feces_composition | 1.30565053 |
| 48 | MP0010352_gastrointestinal_tract_polyps | 1.29911167 |
| 49 | MP0003828_pulmonary_edema | 1.29582499 |
| 50 | MP0005646_abnormal_pituitary_gland | 1.29368593 |
| 51 | MP0003879_abnormal_hair_cell | 1.27502577 |
| 52 | MP0002909_abnormal_adrenal_gland | 1.26598503 |
| 53 | MP0008260_abnormal_autophagy | 1.25548007 |
| 54 | MP0001835_abnormal_antigen_presentation | 1.23827135 |
| 55 | MP0003705_abnormal_hypodermis_morpholog | 1.19995335 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.19801230 |
| 57 | MP0004510_myositis | 1.19799898 |
| 58 | MP0002452_abnormal_antigen_presenting | 1.19414218 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.18701841 |
| 60 | MP0005257_abnormal_intraocular_pressure | 1.18460146 |
| 61 | MP0003690_abnormal_glial_cell | 1.15994643 |
| 62 | MP0005379_endocrine/exocrine_gland_phen | 1.15891936 |
| 63 | MP0009780_abnormal_chondrocyte_physiolo | 1.13913907 |
| 64 | MP0005645_abnormal_hypothalamus_physiol | 1.13200889 |
| 65 | MP0000685_abnormal_immune_system | 1.13097068 |
| 66 | MP0006082_CNS_inflammation | 1.12149638 |
| 67 | MP0005058_abnormal_lysosome_morphology | 1.11816472 |
| 68 | MP0003448_altered_tumor_morphology | 1.10958513 |
| 69 | MP0002723_abnormal_immune_serum | 1.10910560 |
| 70 | MP0005164_abnormal_response_to | 1.10560395 |
| 71 | MP0005171_absent_coat_pigmentation | 1.09064661 |
| 72 | MP0003186_abnormal_redox_activity | 1.09014243 |
| 73 | MP0003075_altered_response_to | 1.08560942 |
| 74 | MP0009643_abnormal_urine_homeostasis | 1.07472951 |
| 75 | MP0004883_abnormal_blood_vessel | 1.07181711 |
| 76 | MP0004130_abnormal_muscle_cell | 1.06798849 |
| 77 | MP0005666_abnormal_adipose_tissue | 1.06332213 |
| 78 | MP0008874_decreased_physiological_sensi | 1.04678875 |
| 79 | MP0002254_reproductive_system_inflammat | 1.04493580 |
| 80 | MP0003724_increased_susceptibility_to | 1.04388336 |
| 81 | MP0001800_abnormal_humoral_immune | 1.03355089 |
| 82 | MP0005409_darkened_coat_color | 1.01172522 |
| 83 | MP0009697_abnormal_copulation | 0.97902445 |
| 84 | MP0002078_abnormal_glucose_homeostasis | 0.96928522 |
| 85 | MP0008469_abnormal_protein_level | 0.96209531 |
| 86 | MP0005464_abnormal_platelet_physiology | 0.96162057 |
| 87 | MP0002405_respiratory_system_inflammati | 0.95548166 |
| 88 | MP0002163_abnormal_gland_morphology | 0.94798023 |
| 89 | MP0008438_abnormal_cutaneous_collagen | 0.94398640 |
| 90 | MP0004043_abnormal_pH_regulation | 0.94238544 |
| 91 | MP0000639_abnormal_adrenal_gland | 0.93369258 |
| 92 | MP0000465_gastrointestinal_hemorrhage | 0.92975381 |
| 93 | MP0004782_abnormal_surfactant_physiolog | 0.92712940 |
| 94 | MP0001542_abnormal_bone_strength | 0.92078318 |
| 95 | MP0002420_abnormal_adaptive_immunity | 0.91720886 |
| 96 | MP0001819_abnormal_immune_cell | 0.91646356 |
| 97 | MP0002166_altered_tumor_susceptibility | 0.91452319 |
| 98 | MP0001502_abnormal_circadian_rhythm | 0.91447324 |
| 99 | MP0005451_abnormal_body_composition | 0.90501795 |
| 100 | MP0003634_abnormal_glial_cell | 0.89927072 |
| 101 | MP0002971_abnormal_brown_adipose | 0.89397535 |
| 102 | MP0000858_altered_metastatic_potential | 0.88202075 |
| 103 | MP0000249_abnormal_blood_vessel | 0.88023728 |
| 104 | MP0003011_delayed_dark_adaptation | 0.87970859 |
| 105 | MP0004142_abnormal_muscle_tone | 0.86818191 |
| 106 | MP0005375_adipose_tissue_phenotype | 0.84764504 |
| 107 | MP0001851_eye_inflammation | 0.84763517 |
| 108 | MP0002896_abnormal_bone_mineralization | 0.84438319 |
| 109 | MP0001853_heart_inflammation | 0.84319572 |
| 110 | MP0005275_abnormal_skin_tensile | 0.83685504 |
| 111 | MP0005387_immune_system_phenotype | 0.83061626 |
| 112 | MP0001790_abnormal_immune_system | 0.83061626 |
| 113 | MP0009642_abnormal_blood_homeostasis | 0.82520761 |
| 114 | MP0006054_spinal_hemorrhage | 0.82440836 |
| 115 | MP0005165_increased_susceptibility_to | 0.82271120 |
| 116 | MP0001986_abnormal_taste_sensitivity | 0.82246295 |
| 117 | MP0008995_early_reproductive_senescence | 0.79482829 |
| 118 | MP0000371_diluted_coat_color | 0.79385709 |
| 119 | MP0009046_muscle_twitch | 0.79254772 |
| 120 | MP0003633_abnormal_nervous_system | 0.79027339 |
| 121 | MP0008872_abnormal_physiological_respon | 0.77802656 |
| 122 | MP0002132_abnormal_respiratory_system | 0.77230562 |
| 123 | MP0003566_abnormal_cell_adhesion | 0.77083262 |
| 124 | MP0002090_abnormal_vision | 0.76415370 |
| 125 | MP0005636_abnormal_mineral_homeostasis | 0.76221463 |
| 126 | MP0002822_catalepsy | 0.75906906 |
| 127 | MP0005334_abnormal_fat_pad | 0.75504352 |
| 128 | MP0000598_abnormal_liver_morphology | 0.75038655 |
| 129 | MP0009765_abnormal_xenobiotic_induced | 0.74744075 |
| 130 | MP0002148_abnormal_hypersensitivity_rea | 0.74687682 |
| 131 | MP0005448_abnormal_energy_balance | 0.74343340 |
| 132 | MP0000604_amyloidosis | 0.73612186 |
| 133 | MP0009763_increased_sensitivity_to | 0.72496813 |
| 134 | MP0002928_abnormal_bile_duct | 0.72494882 |
| 135 | MP0005671_abnormal_response_to | 0.71964015 |
| 136 | MP0009785_altered_susceptibility_to | 0.71722440 |
| 137 | MP0005310_abnormal_salivary_gland | 0.71088992 |
| 138 | MP0006036_abnormal_mitochondrial_physio | 0.68520572 |
| 139 | MP0005376_homeostasis/metabolism_phenot | 0.67955665 |
| 140 | MP0003638_abnormal_response/metabolism_ | 0.67865280 |
| 141 | MP0003953_abnormal_hormone_level | 0.66623147 |
| 142 | MP0003436_decreased_susceptibility_to | 0.64557427 |
| 143 | MP0005670_abnormal_white_adipose | 0.61666091 |
| 144 | MP0005025_abnormal_response_to | 0.61415671 |
| 145 | MP0003172_abnormal_lysosome_physiology | 0.61409519 |
| 146 | MP0001845_abnormal_inflammatory_respons | 0.61335091 |
| 147 | MP0002006_tumorigenesis | 0.61157171 |
| 148 | MP0001501_abnormal_sleep_pattern | 0.59724771 |
| 149 | MP0005084_abnormal_gallbladder_morpholo | 0.59602559 |
| 150 | MP0003631_nervous_system_phenotype | 0.59080467 |
| 151 | MP0005248_abnormal_Harderian_gland | 0.58779376 |
| 152 | MP0003959_abnormal_lean_body | 0.58333410 |
| 153 | MP0009115_abnormal_fat_cell | 0.58050826 |
| 154 | MP0003453_abnormal_keratinocyte_physiol | 0.57224176 |
| 155 | MP0003045_fibrosis | 0.57154221 |
| 156 | MP0002877_abnormal_melanocyte_morpholog | 0.56995927 |
| 157 | MP0005075_abnormal_melanosome_morpholog | 0.55960963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.69665394 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.69202419 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.45899985 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.45899985 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 5.45899985 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.01173697 |
| 7 | Deep venous thrombosis (HP:0002625) | 4.81311182 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.78657281 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 4.50062392 |
| 10 | Complement deficiency (HP:0004431) | 4.19307193 |
| 11 | Xanthomatosis (HP:0000991) | 4.18525660 |
| 12 | Vacuolated lymphocytes (HP:0001922) | 4.01386472 |
| 13 | Joint hemorrhage (HP:0005261) | 3.98179289 |
| 14 | Hypochromic microcytic anemia (HP:0004840) | 3.94617415 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 3.86980760 |
| 16 | Dysostosis multiplex (HP:0000943) | 3.71904681 |
| 17 | Eczematoid dermatitis (HP:0000976) | 3.63538545 |
| 18 | Conjugated hyperbilirubinemia (HP:0002908) | 3.60750759 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 3.52855010 |
| 20 | Fat malabsorption (HP:0002630) | 3.52229635 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.47901852 |
| 22 | Ketosis (HP:0001946) | 3.42964833 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.38060667 |
| 24 | Hyperammonemia (HP:0001987) | 3.38058306 |
| 25 | Hyperglycinemia (HP:0002154) | 3.31237436 |
| 26 | Epidermoid cyst (HP:0200040) | 3.29986803 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 3.29025284 |
| 28 | Increased IgM level (HP:0003496) | 3.25894989 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.24172046 |
| 30 | Increased cerebral lipofuscin (HP:0011813) | 3.23855020 |
| 31 | Neurofibrillary tangles (HP:0002185) | 3.23040467 |
| 32 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.18450095 |
| 33 | Hypolipoproteinemia (HP:0010981) | 3.12803360 |
| 34 | Loss of speech (HP:0002371) | 3.12563825 |
| 35 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.08246981 |
| 36 | Recurrent bacterial skin infections (HP:0005406) | 3.07027799 |
| 37 | Axonal loss (HP:0003447) | 3.03632671 |
| 38 | Myocardial infarction (HP:0001658) | 2.99673279 |
| 39 | Hyperglycinuria (HP:0003108) | 2.96847095 |
| 40 | Recurrent abscess formation (HP:0002722) | 2.96487327 |
| 41 | Ketoacidosis (HP:0001993) | 2.95887202 |
| 42 | Hypoglycemic coma (HP:0001325) | 2.94741651 |
| 43 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.91605514 |
| 44 | Abnormality of complement system (HP:0005339) | 2.90326729 |
| 45 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.84347548 |
| 46 | Abnormality of glycine metabolism (HP:0010895) | 2.84347548 |
| 47 | Steatorrhea (HP:0002570) | 2.82607066 |
| 48 | Spontaneous hematomas (HP:0007420) | 2.79521974 |
| 49 | Hematochezia (HP:0002573) | 2.78087538 |
| 50 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.69621073 |
| 51 | Mutism (HP:0002300) | 2.61672360 |
| 52 | Febrile seizures (HP:0002373) | 2.60429939 |
| 53 | Generalized aminoaciduria (HP:0002909) | 2.60331374 |
| 54 | Disinhibition (HP:0000734) | 2.58780233 |
| 55 | Hypercholesterolemia (HP:0003124) | 2.58579957 |
| 56 | Systemic lupus erythematosus (HP:0002725) | 2.57903511 |
| 57 | Hypoglycemic seizures (HP:0002173) | 2.57444050 |
| 58 | Hypoalphalipoproteinemia (HP:0003233) | 2.56348671 |
| 59 | Increased CSF protein (HP:0002922) | 2.55713966 |
| 60 | Cerebral inclusion bodies (HP:0100314) | 2.55682964 |
| 61 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.51209759 |
| 62 | Hyperbilirubinemia (HP:0002904) | 2.51000133 |
| 63 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.50377844 |
| 64 | Alopecia of scalp (HP:0002293) | 2.47449193 |
| 65 | Spontaneous abortion (HP:0005268) | 2.46628715 |
| 66 | Symptomatic seizures (HP:0011145) | 2.43607880 |
| 67 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.39492701 |
| 68 | Gingival bleeding (HP:0000225) | 2.39457139 |
| 69 | Menorrhagia (HP:0000132) | 2.38619740 |
| 70 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.36648841 |
| 71 | Abnormality of nucleobase metabolism (HP:0010932) | 2.35359244 |
| 72 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.34910003 |
| 73 | Abnormality of purine metabolism (HP:0004352) | 2.34714445 |
| 74 | Vertebral compression fractures (HP:0002953) | 2.33946566 |
| 75 | Turricephaly (HP:0000262) | 2.29780186 |
| 76 | Gingivitis (HP:0000230) | 2.28022954 |
| 77 | Mitral stenosis (HP:0001718) | 2.24599327 |
| 78 | Amyloidosis (HP:0011034) | 2.23040909 |
| 79 | Irritability (HP:0000737) | 2.21356661 |
| 80 | Interstitial pulmonary disease (HP:0006530) | 2.20972721 |
| 81 | Lower limb hyperreflexia (HP:0002395) | 2.20951197 |
| 82 | Alkalosis (HP:0001948) | 2.20256193 |
| 83 | Purpura (HP:0000979) | 2.20129194 |
| 84 | Vascular calcification (HP:0004934) | 2.20099414 |
| 85 | Glomerulonephritis (HP:0000099) | 2.18147988 |
| 86 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.17207972 |
| 87 | Supranuclear gaze palsy (HP:0000605) | 2.17057033 |
| 88 | Abnormality of proline metabolism (HP:0010907) | 2.14784988 |
| 89 | Hydroxyprolinuria (HP:0003080) | 2.14784988 |
| 90 | Rickets (HP:0002748) | 2.14623534 |
| 91 | Neuronal loss in central nervous system (HP:0002529) | 2.14564270 |
| 92 | Delayed CNS myelination (HP:0002188) | 2.14543833 |
| 93 | Progressive neurologic deterioration (HP:0002344) | 2.13609406 |
| 94 | Global brain atrophy (HP:0002283) | 2.12846764 |
| 95 | Metabolic acidosis (HP:0001942) | 2.11845955 |
| 96 | Status epilepticus (HP:0002133) | 2.10857105 |
| 97 | Nuclear cataract (HP:0100018) | 2.10776233 |
| 98 | Growth hormone excess (HP:0000845) | 2.10520556 |
| 99 | Sensorimotor neuropathy (HP:0007141) | 2.10074572 |
| 100 | Polycythemia (HP:0001901) | 2.09742116 |
| 101 | Abnormality of serum amino acid levels (HP:0003112) | 2.09476424 |
| 102 | Pancreatitis (HP:0001733) | 2.08748060 |
| 103 | Apathy (HP:0000741) | 2.05511592 |
| 104 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.03837289 |
| 105 | Osteolytic defects of the hand bones (HP:0009699) | 2.03837289 |
| 106 | Opisthotonus (HP:0002179) | 2.02724468 |
| 107 | Asymmetric septal hypertrophy (HP:0001670) | 2.02637850 |
| 108 | Diminished motivation (HP:0000745) | 2.02591627 |
| 109 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.01290826 |
| 110 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.01126775 |
| 111 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.00647799 |
| 112 | Obstructive sleep apnea (HP:0002870) | 2.00273853 |
| 113 | Mucopolysacchariduria (HP:0008155) | 1.99657117 |
| 114 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.99657117 |
| 115 | Nephritis (HP:0000123) | 1.99483372 |
| 116 | Basal ganglia calcification (HP:0002135) | 1.97696597 |
| 117 | Progressive inability to walk (HP:0002505) | 1.96162864 |
| 118 | Hypochromic anemia (HP:0001931) | 1.96064934 |
| 119 | Metaphyseal irregularity (HP:0003025) | 1.95697654 |
| 120 | Distal lower limb muscle weakness (HP:0009053) | 1.93691014 |
| 121 | Retinal atrophy (HP:0001105) | 1.93521572 |
| 122 | Hemorrhage of the eye (HP:0011885) | 1.92509933 |
| 123 | Hand muscle atrophy (HP:0009130) | 1.92507507 |
| 124 | Pigmentary retinal degeneration (HP:0001146) | 1.92346854 |
| 125 | Premature loss of primary teeth (HP:0006323) | 1.91587243 |
| 126 | Acute hepatic failure (HP:0006554) | 1.91050219 |
| 127 | Lethargy (HP:0001254) | 1.91017732 |
| 128 | Protuberant abdomen (HP:0001538) | 1.89527580 |
| 129 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.89225095 |
| 130 | Pathologic fracture (HP:0002756) | 1.88666917 |
| 131 | Malnutrition (HP:0004395) | 1.88641522 |
| 132 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.88323217 |
| 133 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.88323217 |
| 134 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.88323217 |
| 135 | Tetraparesis (HP:0002273) | 1.88237036 |
| 136 | Gout (HP:0001997) | 1.86652733 |
| 137 | Pustule (HP:0200039) | 1.86074564 |
| 138 | Joint swelling (HP:0001386) | 1.85261331 |
| 139 | Orchitis (HP:0100796) | 1.84616727 |
| 140 | Cardiovascular calcification (HP:0011915) | 1.83313684 |
| 141 | Fair hair (HP:0002286) | 1.82838709 |
| 142 | Skin nodule (HP:0200036) | 1.82629799 |
| 143 | Bone pain (HP:0002653) | 1.81269639 |
| 144 | Muscle fiber splitting (HP:0003555) | 1.81238211 |
| 145 | Dementia (HP:0000726) | 1.80278154 |
| 146 | Upper motor neuron abnormality (HP:0002127) | 1.80042543 |
| 147 | Recurrent skin infections (HP:0001581) | 1.79642319 |
| 148 | Elevated alkaline phosphatase (HP:0003155) | 1.79550429 |
| 149 | Hepatocellular carcinoma (HP:0001402) | 1.78177373 |
| 150 | Pulmonary infiltrates (HP:0002113) | 1.77830591 |
| 151 | Osteomalacia (HP:0002749) | 1.77346375 |
| 152 | Abnormality of the periventricular white matter (HP:0002518) | 1.75929423 |
| 153 | Peripheral demyelination (HP:0011096) | 1.74706762 |
| 154 | Distal upper limb amyotrophy (HP:0007149) | 1.73935507 |
| 155 | Upper limb amyotrophy (HP:0009129) | 1.73935507 |
| 156 | Pulmonary embolism (HP:0002204) | 1.72387621 |
| 157 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.71667190 |
| 158 | Myositis (HP:0100614) | 1.71273911 |
| 159 | Hypophosphatemia (HP:0002148) | 1.69271963 |
| 160 | Renal cortical cysts (HP:0000803) | 1.69022679 |
| 161 | Oligomenorrhea (HP:0000876) | 1.68344344 |
| 162 | J-shaped sella turcica (HP:0002680) | 1.68127026 |
| 163 | Flat acetabular roof (HP:0003180) | 1.66739052 |
| 164 | Mediastinal lymphadenopathy (HP:0100721) | 1.65525819 |
| 165 | Urinary incontinence (HP:0000020) | 1.65339636 |
| 166 | Conjunctival telangiectasia (HP:0000524) | 1.65333639 |
| 167 | Difficulty running (HP:0009046) | 1.64477434 |
| 168 | Hyperparathyroidism (HP:0000843) | 1.63545471 |
| 169 | Esophageal varix (HP:0002040) | 1.63392805 |
| 170 | Optic neuritis (HP:0100653) | 1.62372556 |
| 171 | Retrobulbar optic neuritis (HP:0100654) | 1.62372556 |
| 172 | Mucosal telangiectasiae (HP:0100579) | 1.59997854 |
| 173 | Cerebral aneurysm (HP:0004944) | 1.57461798 |
| 174 | Spinal muscular atrophy (HP:0007269) | 1.56674060 |
| 175 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.55844621 |
| 176 | Vascular tortuosity (HP:0004948) | 1.54847653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PINK1 | 3.55124945 |
| 2 | MAPK15 | 3.30081309 |
| 3 | INSRR | 2.57621001 |
| 4 | BLK | 2.55423876 |
| 5 | MAP3K2 | 2.49478997 |
| 6 | MAP3K14 | 2.46773484 |
| 7 | MAP3K6 | 2.44370237 |
| 8 | ACVR1B | 2.36015302 |
| 9 | ICK | 2.18335034 |
| 10 | BCKDK | 2.15388557 |
| 11 | TGFBR2 | 2.09337178 |
| 12 | AKT3 | 2.05200288 |
| 13 | RIPK1 | 1.88425756 |
| 14 | CAMKK2 | 1.86943864 |
| 15 | MATK | 1.86581223 |
| 16 | TAOK3 | 1.82267335 |
| 17 | FRK | 1.79146211 |
| 18 | DDR2 | 1.74939583 |
| 19 | YES1 | 1.73818310 |
| 20 | SIK1 | 1.72922702 |
| 21 | MAP3K1 | 1.65251738 |
| 22 | STK24 | 1.62342878 |
| 23 | MAP3K3 | 1.58808193 |
| 24 | JAK1 | 1.56913877 |
| 25 | FGFR4 | 1.53331739 |
| 26 | TXK | 1.52769441 |
| 27 | MAP3K11 | 1.51706751 |
| 28 | TYK2 | 1.50688081 |
| 29 | IKBKE | 1.49776207 |
| 30 | PRKD2 | 1.49576782 |
| 31 | MAP2K7 | 1.44120750 |
| 32 | PRPF4B | 1.43585023 |
| 33 | SGK3 | 1.42084950 |
| 34 | CSK | 1.39612765 |
| 35 | BMX | 1.39237219 |
| 36 | KSR2 | 1.36556065 |
| 37 | SGK2 | 1.33534526 |
| 38 | ZAP70 | 1.32364736 |
| 39 | IRAK3 | 1.31384928 |
| 40 | BMPR2 | 1.27771653 |
| 41 | MAP3K12 | 1.23686408 |
| 42 | FES | 1.20477028 |
| 43 | IKBKB | 1.19735245 |
| 44 | MAP2K4 | 1.18736110 |
| 45 | FGFR3 | 1.14277159 |
| 46 | MAP3K13 | 1.13883641 |
| 47 | MAPK11 | 1.13880541 |
| 48 | DYRK1B | 1.13774604 |
| 49 | FGR | 1.13616766 |
| 50 | TNK2 | 1.13575837 |
| 51 | CAMKK1 | 1.13419328 |
| 52 | DAPK1 | 1.12888661 |
| 53 | PDPK1 | 1.08549154 |
| 54 | CSF1R | 1.08184599 |
| 55 | UHMK1 | 1.05379663 |
| 56 | ARAF | 1.04488897 |
| 57 | JAK2 | 1.00136121 |
| 58 | SGK223 | 0.99865084 |
| 59 | SGK494 | 0.99865084 |
| 60 | PRKAA2 | 0.99355404 |
| 61 | NLK | 0.99229719 |
| 62 | MOS | 0.98906162 |
| 63 | GRK7 | 0.94567903 |
| 64 | PDK1 | 0.92736011 |
| 65 | NTRK3 | 0.92127697 |
| 66 | TBK1 | 0.91435066 |
| 67 | TAOK1 | 0.88882431 |
| 68 | EPHB1 | 0.88380540 |
| 69 | JAK3 | 0.87616117 |
| 70 | PRKAA1 | 0.87336983 |
| 71 | IRAK4 | 0.85715774 |
| 72 | ERBB4 | 0.82298458 |
| 73 | CAMK2G | 0.81840239 |
| 74 | PRKCH | 0.81789549 |
| 75 | DAPK2 | 0.81493482 |
| 76 | EPHA3 | 0.81031909 |
| 77 | MAP2K3 | 0.80557703 |
| 78 | PDGFRA | 0.80276258 |
| 79 | PIK3CG | 0.79921466 |
| 80 | GSK3A | 0.79155195 |
| 81 | PRKG2 | 0.78223220 |
| 82 | TIE1 | 0.77622101 |
| 83 | PDGFRB | 0.77517898 |
| 84 | GRK1 | 0.76308683 |
| 85 | RPS6KB1 | 0.75923655 |
| 86 | TRIB3 | 0.75272543 |
| 87 | SIK3 | 0.73899388 |
| 88 | STK38 | 0.73817763 |
| 89 | FER | 0.72831196 |
| 90 | RIPK4 | 0.72632480 |
| 91 | CHUK | 0.72561725 |
| 92 | KSR1 | 0.71478209 |
| 93 | PIM1 | 0.71223037 |
| 94 | SGK1 | 0.70935525 |
| 95 | MUSK | 0.70905671 |
| 96 | RPS6KA2 | 0.70880300 |
| 97 | ERN1 | 0.69904255 |
| 98 | CAMK1G | 0.69688598 |
| 99 | SIK2 | 0.67670901 |
| 100 | STK11 | 0.66381429 |
| 101 | NEK9 | 0.66163196 |
| 102 | MARK2 | 0.66053945 |
| 103 | PHKG2 | 0.66039173 |
| 104 | PHKG1 | 0.66039173 |
| 105 | HCK | 0.65809628 |
| 106 | CASK | 0.65329102 |
| 107 | TRPM7 | 0.64846590 |
| 108 | HIPK2 | 0.64489468 |
| 109 | MAPK12 | 0.64448472 |
| 110 | ADRBK2 | 0.63147807 |
| 111 | RET | 0.62877060 |
| 112 | CDC42BPA | 0.62580541 |
| 113 | NEK6 | 0.62136951 |
| 114 | PIM2 | 0.61828658 |
| 115 | IRAK1 | 0.61452907 |
| 116 | RPS6KA6 | 0.60002617 |
| 117 | MAP3K9 | 0.59799307 |
| 118 | RPS6KL1 | 0.59718645 |
| 119 | RPS6KC1 | 0.59718645 |
| 120 | PKN1 | 0.55746127 |
| 121 | MYLK | 0.54217610 |
| 122 | CDK6 | 0.53157705 |
| 123 | PRKACG | 0.53057625 |
| 124 | PTK2B | 0.52770921 |
| 125 | PTK6 | 0.52169594 |
| 126 | BMPR1B | 0.51838249 |
| 127 | MAPK7 | 0.51223027 |
| 128 | IRAK2 | 0.50931869 |
| 129 | SYK | 0.50202527 |
| 130 | GRK5 | 0.49166485 |
| 131 | TAOK2 | 0.48597574 |
| 132 | LCK | 0.48318330 |
| 133 | TESK1 | 0.47730235 |
| 134 | BTK | 0.47511399 |
| 135 | TNIK | 0.47108562 |
| 136 | LATS2 | 0.46997118 |
| 137 | LMTK2 | 0.46888907 |
| 138 | EPHA4 | 0.46789487 |
| 139 | MST1R | 0.46319024 |
| 140 | MAP3K7 | 0.46094514 |
| 141 | PRKCZ | 0.45374017 |
| 142 | CAMK2A | 0.45103620 |
| 143 | LYN | 0.43846083 |
| 144 | CAMK1D | 0.43562494 |
| 145 | ABL2 | 0.43368431 |
| 146 | TTN | 0.42553145 |
| 147 | STK3 | 0.42511636 |
| 148 | SCYL2 | 0.42232876 |
| 149 | MAP4K1 | 0.41213573 |
| 150 | MAPK4 | 0.41014470 |
| 151 | MAP3K4 | 0.40523084 |
| 152 | OXSR1 | 0.40489655 |
| 153 | FYN | 0.40317423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.03843144 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.59276683 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.27162240 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.91889271 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.73702609 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.51425965 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.46833444 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.38780445 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.38211736 |
| 10 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.37225186 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.30719270 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.15879051 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.03802553 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.00267108 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 1.99088371 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.93189162 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89227076 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.88176245 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.88127798 |
| 20 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.86066528 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.83543308 |
| 22 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.82612120 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.77320656 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.73283434 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.71497879 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71477948 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.71146892 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.68745015 |
| 29 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.67306602 |
| 30 | ABC transporters_Homo sapiens_hsa02010 | 1.65294907 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.61807790 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.61132955 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.59881321 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.59770088 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.58051292 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.56476623 |
| 37 | Tuberculosis_Homo sapiens_hsa05152 | 1.55410300 |
| 38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.53524629 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.53146628 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 1.50238425 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38170462 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.35708189 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.35001117 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32083801 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.28880564 |
| 46 | Asthma_Homo sapiens_hsa05310 | 1.27551584 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.25543822 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.24841677 |
| 49 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.24811610 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.22340557 |
| 51 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.22061707 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.19433968 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.17916031 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.15721957 |
| 55 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15200701 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.06733225 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.05233944 |
| 58 | Malaria_Homo sapiens_hsa05144 | 1.05092182 |
| 59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.04782070 |
| 60 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.03718449 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03302451 |
| 62 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.02872433 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.02665738 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.01808142 |
| 65 | Mineral absorption_Homo sapiens_hsa04978 | 0.98022011 |
| 66 | Amoebiasis_Homo sapiens_hsa05146 | 0.97118091 |
| 67 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.94901790 |
| 68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92363526 |
| 69 | Renin secretion_Homo sapiens_hsa04924 | 0.92257585 |
| 70 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.90648853 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85262508 |
| 72 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.84296511 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81752085 |
| 74 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.80276586 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78439006 |
| 76 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.76790296 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75531834 |
| 78 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.75150427 |
| 79 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.74922615 |
| 80 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.74228218 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74110557 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.74019081 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.73639786 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.73398582 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73312854 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72454365 |
| 87 | Salmonella infection_Homo sapiens_hsa05132 | 0.72434429 |
| 88 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.72302090 |
| 89 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.72288364 |
| 90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71785159 |
| 91 | Influenza A_Homo sapiens_hsa05164 | 0.71263185 |
| 92 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71236077 |
| 93 | Legionellosis_Homo sapiens_hsa05134 | 0.70874231 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.70799349 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69742912 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.69636199 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67567600 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.67065115 |
| 99 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66589015 |
| 100 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.65450449 |
| 101 | Long-term potentiation_Homo sapiens_hsa04720 | 0.65091774 |
| 102 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.65042193 |
| 103 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64995746 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64006096 |
| 105 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61405483 |
| 106 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60973386 |
| 107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60502006 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59770930 |
| 109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58722645 |
| 110 | Sulfur relay system_Homo sapiens_hsa04122 | 0.58519564 |
| 111 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55186995 |
| 112 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.55142762 |
| 113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55074064 |
| 114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54478438 |
| 115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52808930 |
| 116 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52792914 |
| 117 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.52292539 |
| 118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51347662 |
| 119 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50602594 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.50473972 |
| 121 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50005600 |
| 122 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.47550747 |
| 123 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.47230926 |
| 124 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.47009939 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46639987 |
| 126 | Allograft rejection_Homo sapiens_hsa05330 | 0.46028346 |
| 127 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44619701 |
| 128 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.44083777 |
| 129 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42685913 |
| 130 | Measles_Homo sapiens_hsa05162 | 0.40138459 |
| 131 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39040064 |
| 132 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38391790 |
| 133 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.38282664 |
| 134 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.38127639 |
| 135 | Carbon metabolism_Homo sapiens_hsa01200 | 0.37757697 |
| 136 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36041925 |
| 137 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35107212 |
| 138 | GABAergic synapse_Homo sapiens_hsa04727 | 0.34266495 |
| 139 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33941232 |
| 140 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.33844883 |
| 141 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33838068 |
| 142 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.31368671 |
| 143 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.28815202 |
| 144 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.28105166 |
| 145 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23338951 |
| 146 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.22449211 |
| 147 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.22034040 |
| 148 | Insulin resistance_Homo sapiens_hsa04931 | 0.20769633 |
| 149 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.20526917 |
| 150 | Insulin secretion_Homo sapiens_hsa04911 | 0.18381390 |
| 151 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.17314470 |
| 152 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.17093348 |
| 153 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.16108740 |
| 154 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.15794995 |
| 155 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.15449727 |
| 156 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.15282224 |
| 157 | Lysosome_Homo sapiens_hsa04142 | 0.15036375 |
| 158 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.14854330 |
| 159 | Taste transduction_Homo sapiens_hsa04742 | 0.14306596 |
| 160 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.13480956 |
| 161 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.13134239 |
| 162 | Olfactory transduction_Homo sapiens_hsa04740 | 0.12928627 |
| 163 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.11742276 |
| 164 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.10996907 |
| 165 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.09411609 |
| 166 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09075553 |
| 167 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.07835675 |
| 168 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.06533704 |

